T. Rowe Price Mid-Cap Growth (RPMGX)
Nasdaq • Currently up 0.59 (+0.58%) in today's trading session
1 member of Congress has disclosed 3 trades in T. Rowe Price Mid-Cap Growth (RPMGX) via STOCK Act filings. The most recent disclosure was a purchase by Jim Costa on 14 December 2023. Aggregate disclosed activity totals roughly $16K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).
T. Rowe Price Mid-Cap Growth is currently trading at $103.12, positioned at 87% of its 52-week range ($90.75 – $105.04).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
T. Rowe Price Mid-Cap Growth Price History and Technical Analysis
Congressional Trading Activity for RPMGX
| No data | |||||||
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about RPMGX
- Which members of Congress have traded RPMGX?
- 1 member of Congress has disclosed 3 trade in T. Rowe Price Mid-Cap Growth (RPMGX) under the STOCK Act: Jim Costa.
- When was RPMGX most recently disclosed by Congress?
- The most recent RPMGX disclosure was a purchase by Jim Costa on 14 December 2023.
- What is the total disclosed congressional trading volume for RPMGX?
- Members of Congress have disclosed approximately $16K in RPMGX purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
- How can I track new congressional trades in RPMGX?
- This RPMGX page updates as soon as new STOCK Act disclosures are filed for T. Rowe Price Mid-Cap Growth. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track RPMGX in Congress
See when politicians buy or sell this stock